期刊文献+

临床研究数据安全监察计划与伦理审查 被引量:3

Data Safety Monitoring Plan and Ethical Review of Clinical Research
下载PDF
导出
摘要 国内外临床研究与伦理审查法律法规、指导原则等多处提及数据安全监察计划(DSMP)及数据安全监察委员会(DSMB)。研究者作为受试者保护的第一责任人应把相关要求落实在方案设计中。作为临床研究保驾护航的伦理委员会,应从伦理审查的视角出发思考如何通过对临床研究方案中数据与安全监察计划的审查,以更好地对其科学性进行把关。在介绍临床研究DSMP及DSMB内涵的基础上,提出如何通过伦理审查促进临床研究数据监察计划的落实与实践的构想。 Data Safety Monitoring Program (DSMP) and Data Safety Monitoring Board (DSMB) are mentioned in clinical research and ethical review laws, regulations and guidelines at home and abroad. The investigator, as the first person being responsible for the subject protection, should implement the relevant requirements in the design of the project. Ethics committee should consider how to improve scientific review of the clinical research by reviewing DSMP. Based on the introduction of DSMP and DSMB of clinical research, this paper proposes a framework on how to promote the implementation and practice of the clinical research data monitoring plan through ethical review.
作者 黎欣盈 张念樵 陆麒 LI Xin-ying;ZHANG Nian-qiao;LU Qi(Ethics Committee, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, China)
出处 《医学与哲学》 2019年第13期32-36,共5页 Medicine and Philosophy
基金 2018年广州中医药大学第一附属医院创新强院工程(二期)项目(高水平医院建设C2-4)
关键词 临床研究 数据安全监察计划 数据安全监察委员会 伦理审查 受试者保护 clinical research Data and Safety Monitoring Plan Data and Safety Monitoring Board ethical review subject protection
  • 相关文献

参考文献2

二级参考文献20

  • 1卜擎燕(译),汪秀琴(校),熊宁宁(校).数据与安全监察委员会的建立及其职能的操作指南——2005年世界卫生组织(WHO)/热带病研究和培训特别计划(TDR)[J].中国新药杂志,2007,16(9):657-662. 被引量:6
  • 2[1]ICH harmonised tripartite guideline. E9, statistical principles for clinical trials[S]. 1998
  • 3[2]Council for International Organizations of Medical Sciences (CIOM). International Ethical Guidelines for Biomedical Research Involving Human Subjects[S]. 2002
  • 4[4]National Institutes of Health. Data and Safety Monitoring Board (DSMB) Guidelines[S]. 2001
  • 5[5]National Institute on Drug Abuse (NIDA). Data and Safety Monitoring Board Standard Operating Procedures[S]. 2000
  • 6[6]National Cancer Institute of United States. Policy of The National Cancer Institute for Data and Safety Monitoring of Clinical Trials[S]. 1999
  • 7National Institutes of Health. NIH policy for data and safety monitoring[EB/OL]. (1998-06-10). http://grants, nih. gov/grants/guide/notiee-files/ not98 - 084. html.
  • 8National Institutes of Health. Further guidance on a data and safety monitoring for phase Ⅰ and phase Ⅱ trials[EB/OL]. ( 2000-06-05 ). http://grants. nih. gov/grants/guide/notice-files/NOT-OD-00-038, html.
  • 9Harvey Murff. Data and safety monitoring in clinical trials[EB/OL]. http://www.mc. vanderbilt. edu/gcrc/workshop _ files/2004-10-08, ppt.
  • 10NIDA. Data and safety monitoring board standard operating procedures. (2000-05-26). http://www. nida. nih. gov/funding/DSMB_SOP, html.

共引文献13

同被引文献35

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部